Patients News | pharmaphorum

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen and Arrowhead strike $3.7bn RNAi deal

Janssen has struck a deal with Arrowhead Pharmaceuticals to develop an RNA interference drug to treat hepatitis B viral infection, worth up to $3.7 billion.

News

MS campaigner Trishna Bharadia scoops Woman of the Year awar...

Multiple sclerosis campaigner Trishna Bharadia has been named Woman of the Year at the 2018 Asian Achievers Awards during a glittering ceremony in London.

News

Lack of blood cancer awareness in China and Japan - Janssen ...

Janssen has published a report revealing significant gaps in understanding of blood cancer in individuals in China and Japan, calling for action to improve awareness about the disease in th

Views & Analysis

Can pharma halt the world's obesity crisis?

Lancet research reveals scale of problem

News

NICE backs funding for Kyowa Kirin's bone disorder drug

Children in England and Wales with a rare inherited disorder causing soft and weak bones can have access to a new therapy after NICE said Kyowa Kirin’s Crysvita can receive regular NHS fund

News

FDA warns of genital gangrene risk with diabetes drug class

The US regulator released an official risk warning of a rare genital infection identified in 12 patients, including one fatality, after using SGLT2 class drugs for type 2 diabetes.

Janssen and Arrowhead strike $3.7bn RNAi deal

MS campaigner Trishna Bharadia scoops Woman of the Year awar...

Lack of blood cancer awareness in China and Japan - Janssen ...

Can pharma halt the world's obesity crisis?

NICE backs funding for Kyowa Kirin's bone disorder drug

FDA warns of genital gangrene risk with diabetes drug class

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

News

Editor's Picks